CADILA FDA Approval ANDA 077734

ANDA 077734

CADILA

FDA Drug Application

Application #077734

Documents

Letter2011-05-10

Application Sponsors

ANDA 077734CADILA

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORALEQ 5MG BASE0ESCITALOPRAM OXALATEESCITALOPRAM OXALATE
002TABLET;ORALEQ 10MG BASE0ESCITALOPRAM OXALATEESCITALOPRAM OXALATE
003TABLET;ORALEQ 20MG BASE0ESCITALOPRAM OXALATEESCITALOPRAM OXALATE

FDA Submissions

ORIG1AP2012-09-11

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77734
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.